Arq Bras CardiolabcArquivos Brasileiros de CardiologiaArq. Bras. Cardiol.0066-782X1678-4170Sociedade Brasileira de Cardiologia - SBCRzkLzkM4V5h3jDBv98FqBQGS0066-782X2021000500854abc.2020119110.36660/abc.20201191Carta ao EditorTroponina-T e Peptídeo Natriurético tipo B na COVID-190000-0001-8292-6656YasriSora1WiwanitkitViroj1Dr. DY Patil UniversityPuneÍndiaDr. DY Patil University, Pune - ÍndiaCorrespondência: Sora Yasri • Private Academic Practice Bangkok 1-2012021 – Tailândia E-mail: sorayasri@outlook.co.th160420210420211164854854091120201612202016122020This is an open-access article distributed under the terms of the Creative Commons Attribution LicensePalavras-chaveCOVID-19/complicaçõesBetacoronavírusMortalidadeHospitalizaçãoMiocarditeBiomarcadoresTroponina TPeptídeo Natriurético Tipo B
Caro Editor,
Gostaríamos de compartilhar ideias sobre a publicação “Valor Prognóstico da Troponina T e do Peptídeo Natriurético Tipo B em Pacientes Internados por COVID-19.1 Almeida Jr. et al.,1 relataram o uso da caixa de memória como uma ferramenta para apoiar o luto e concluíram que “Nas primeiras 24h de admissão, TnT, mas não o BNP, foi marcador independente de mortalidade ou necessidade de ventilação mecânica invasiva.”1 Na COVID-19, a complicação cardíaca é possível e comum em infecções graves.2 O comprometimento miocárdico é um problema cardíaco comum e a miocardite imunológica é uma importante manifestação grave da COVID-19.3 Portanto, a troponina-T, que é um bom biomarcador de lesão miocárdica, pode ter um bom fator prognóstico para a gravidade da COVID-19. No entanto, deve-se notar que problemas renais também podem induzir alterações da troponina-T4 Se o paciente tiver um problema renal subjacente, a interpretação da troponina-T em pacientes com COVID-19 deve ser cuidadosa.
ReferênciasAlmeidaGLGJuniorBragaFJorgeJKNobreGFKalichszteinMFariaPMPPrognostic Value of Troponin-T and B-Type Natriuretic Peptide in Patients Hospitalized for COVID-19Arq Bras Cardiol20201011546606661. Almeida Junior GLG, Braga F, Jorge JK, Nobre GF, Kalichsztein M, Faria PMP, et al. Prognostic Value of Troponin-T and B-Type Natriuretic Peptide in Patients Hospitalized for COVID-19. Arq Bras Cardiol. 2020 Oct;115(4):660-6.GuoTFanYChenMWuXZhangLHeTCardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)JAMA Cardiol20200701578118182. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1;5(7):811-8KoganEABerezovskiyYSBlagovaOVKuklevaADBogachevaGAKurilinaEVMiocarditis in Patients with COVID-19 Confirmed by ImmunohistochemicalKardiologiia202006196074103. Kogan EA, Berezovskiy YS, Blagova OV, Kukleva AD, Bogacheva GA, Kurilina EV, et al. Miocarditis in Patients with COVID-19 Confirmed by Immunohistochemical. Kardiologiia. 2020 Jun 19;60(7):4-10.BozbasHYildirirAMuderrisogluHCardiac enzymes, renal failure and renal transplantationClin Med Res2006034179844. Bozbas H, Yildirir A, Muderrisoglu H. Cardiac enzymes, renal failure and renal transplantation. Clin Med Res. 2006 Mar;4(1):79-84.Letter to the EditorTroponin-T and B-Type Natriuretic Peptide in COVID-190000-0001-8292-6656YasriSora1WiwanitkitViroj1PuneIndiaDr. DY Patil University, Pune - IndiaMailing Address: Sora Yasri • Private Academic Practice Bangkok 1-2012021 – Tailândia E-mail: sorayasri@outlook.co.thKeywordsCOVID-19/complicationsBetacoronavirusMortalityHospitalizationMyocarditisBiomarkersTroponi-TNatriuretic B-Type
Dear Editor,
We would like to share ideas on the publication “Prognostic Value of Troponin-T and B-Type Natriuretic Peptide in Patients Hospitalized for COVID-19 [1].” Almeida Jr. et al.1 reported using Memory box as a tool to support grief and concluded that “In the first 24h of admission, TnT, but not BNP, was an independent marker of mortality or need for invasive mechanical ventilation.”1 In COVID-19, cardiac complication is possible and is common in severe infection.2 Myocardial involvement is a common cardiac problem and immunological myocarditis is an important severe manifestation of COVID-19.3 Therefore, troponin-T, which is a good biomarker for myocardial injury, might have good prognostic factor for severity of COVID-19. Nevertheless, it should be noted that renal problems can also induce troponin-T abnormality.4 If the patient has an underlying renal problem, the interpretation of troponin-T in COVID-19 patients must be careful.